239
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?

, , , , , , , , , , & show all
Pages 413-420 | Received 23 Mar 2021, Accepted 20 Mar 2022, Published online: 19 Apr 2022

References

  • Lumsden MA. The NICE guideline – menopause: diagnosis and management. Climacteric. 2016;19(5):426–429.
  • Burger HG. The endocrinology of the menopause. J Steroid Biochem Mol Biol. 1999;69(1–6):31–35.
  • Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168.
  • Weismiller DG. Menopause. Prim Care. 2009;36(1):199–226.
  • The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24:728–753.
  • Nastri CO, Lara LA, Ferriani RA, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Syst Rev. 2013;(6):Cd009672.
  • Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215.
  • Smail L, Jassim G, Shakil A. Menopause-specific quality of life among emirati women. IJERPH. 2019;17(1):40.
  • Baber RJ, Panay N, Fenton A. IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
  • Wang Y, Yang X, Li X, et al. Knowledge and personal use of menopausal hormone therapy among chinese obstetrician-gynecologists: results of a survey. Menopause. 2014;21(11):1190–1196.
  • Velentzis LS, Banks E, Sitas F, et al. Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: results from a National, Cross-Sectional Study. Plos One. 2016;11(3):e0146494.
  • Gass ML, Stuenkel CA, Utian WH, et al. Use of compounded hormone therapy in the United States: report of the North American Menopause Society Survey. Menopause. 2015;22(12):1276–1284.
  • Yeganeh L, Boyle J, Teede H, et al. Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric. 2017;20(4):348–355.
  • Vallejo MS, Witis S, Ojeda E, et al. Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy? Climacteric. 2016;19(4):387–392.
  • Tserotas K, Blümel JE. Menopause research in Latin America. Climacteric. 2019;22(1):17–21.
  • Buhling KJ, von Studnitz FS, Jantke A, et al. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women’s Health Initiative study: results of a survey. Menopause. 2012;19(10):1088–1091.
  • Constantine GD, Archer DF, Graham S, et al. Prescribing of FDA-approved and compounded hormone therapy differs by specialty. Menopause. 2016;23(10):1075–1082.
  • Pinkerton JV. Hormone therapy: key points from NAMS 2017 position statement. Clin Obstet Gynecol. 2018;61(3):447–453.
  • Paszkowski T, Bińkowska M, Dębski R, et al. Menopausal hormone therapy in questions and answers – a manual for physicians of various specialties. Prz Menopauzalny. 2019;18(1):1–8.
  • Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA. 1996;275(5):370–375.
  • Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev. 2000;(2):Cd001018.
  • Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;(3):Cd002229.
  • Stute P, Neulen J, Wildt L. The impact of micronized progesterone on the endometrium: a systematic review. Climacteric. 2016;19(4):316–328.
  • [Chinese guideline on menopause management and menopause hormone therapy (2018)]. Zhonghua fu chan ke za zhi. 2018;53(11):729–739.
  • Devi G, Sugiguchi F, Pedersen AT, et al. Current attitudes on self-use and prescription of hormone therapy among New York City gynaecologists. Menopause Int. 2013;19(3):121–126.
  • Danckers L, Blümel JE, Witis S, et al. Personal and professional use of menopausal hormone therapy among gynecologists: a multinational study (REDLINC VII). Maturitas. 2016;87:67–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.